Medscape3d
HER2 Overexpression/Amplification and Trastuzumab Treatment in Advanced Ovarian Cancer: A GINECO Phase II Study
All positive (IHC 3+) and doubtful (IHC 2+) cases were screened by fl uorescence in situ hybridization (FISH). Patients with HER2 gene amplification, normal left ventricular ejection fraction ...
Pharmabiz4d
US FDA approves Roche’s companion diagnostic to identify patients with biliary tract cancer eligible for HER2-targeted treatment with Ziihera
US FDA approves Roche’s companion diagnostic to identify patients with biliary tract cancer eligible for HER2-targeted treatment with Ziihera: Tucson, Arizona Tuesday, November ...
GlobalData on MSN3d
FDA approves Roche’s PATHWAY HER2 test for biliary tract cancer
The US Food and Drug Administration (FDA) has approved a label expansion for Roche’s PATHWAY anti-HER2/neu (4B5) Rabbit Monoclonal Primary Antibody test, into biliary tract cancer (BTC). This approval ...
Medscape11y
Reverse-Phase Protein Microarray Highlights HER2 Signaling Activation in Immunohistochemistry/FISH/HER2-Negative Breast Cancers
The analysis was performed on independent study sets of HER2-positive and negative/low breast cancers, already analyzed by central immunohistochemistry (IHC) and FISH testing. Phospho-HER2 and ...
腾讯网21d
T-DXd 为 HR+/HER2 低表达 mBC 两线内分泌经治患者带来治疗新突破
案例概述 41 岁女性患者，初诊左侧乳腺浸润性导管癌 cT3NxM0，IIIC 期，LuminalA 型（HER2 IHC 2+/FISH-），接受新辅助化疗、左侧乳腺癌改良根治术 ...